Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CBMG

Cellular Biomedicine Group (CBMG) Stock Price, News & Analysis

Cellular Biomedicine Group logo

About Cellular Biomedicine Group Stock (NASDAQ:CBMG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$17.67
$19.75
52-Week Range
N/A
Volume
8,375 shs
Average Volume
129,776 shs
Market Capitalization
$384.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBMG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellular Biomedicine Group and its competitors with MarketBeat's FREE daily newsletter.

CBMG Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
See More Headlines

CBMG Stock Analysis - Frequently Asked Questions

Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) issued its quarterly earnings results on Monday, November, 9th. The biotechnology company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.63) by $0.25. The biotechnology company earned $0.03 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellular Biomedicine Group investors own include CRISPR Therapeutics (CRSP), Anavex Life Sciences (AVXL), Aduro Biotech (ADRO), Allena Pharmaceuticals (ALNA), Amarin (AMRN), Bristol Myers Squibb (BMY) and Intellia Therapeutics (NTLA).

Company Calendar

Last Earnings
11/09/2020
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:CBMG
CIK
1378624
Fax
N/A
Employees
217
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$49.98 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-144.80%
Return on Assets
-61.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.47
Quick Ratio
0.47

Sales & Book Value

Annual Sales
$340 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.89 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
19,478,000
Free Float
N/A
Market Cap
$384.69 million
Optionable
Optionable
Beta
1.35
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:CBMG) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners